title: Acquired angioedema responding to rituximab.
authors.forename: Amr
authors.initials: A
authors.lastname: Hassan
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Amarger
authors.forename: Arlette
authors.initials: A
authors.lastname: Tridon
authors.forename: Denise
authors.initials: D
authors.lastname: Ponard
authors.forename: Pierre
authors.initials: P
authors.lastname: Souteyrand
authors.forename: Michel
authors.initials: M
authors.lastname: D'Incan
mesh_terms: D000369:Aged, 80 and over; D000799:Angioedema / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood; D050718:Complement C1 Inhibitor Protein / Q000276:immunology / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D050718:Complement C1 Inhibitor Protein; D003181:Complement C4; D007155:Immunologic Factors; D000069283:Rituximab